Skip to content
Accessibility help
Search NICE…
Skip to content
Menu
Sign in
Guidance
Standards and indicators
Life sciences
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Clinical Knowledge Summaries (CKS)
About
Home
NICE guidance
Published
Published
Guidance, NICE advice and quality standards
Skip to filters
Skip to results
Published
In consultation
In development
Awaiting development
Topic selection
Filter (14 active)
Skip to results
Filter by title or keyword
Filter
Last updated date
Last updated date
From date
To date
Apply date filters
Area of interest
Area of interest
Antimicrobial prescribing (19)
COVID-19 (2)
Type
(
2 selected
)
Type
Guidance (700)
Quality standard (0)
Guidance programme
(
11 selected
)
Guidance programme
Antimicrobial prescribing guidelines (18)
Cancer service guidelines (0)
Clinical guidelines (136)
COVID-19 rapid guidelines (2)
Diagnostics guidance (25)
Health technology evaluations (17)
Highly specialised technologies guidance (23)
Interventional procedures guidance (172)
Medical technologies guidance (55)
Medicines practice guidelines (0)
NICE guidelines (177)
Public health guidelines (14)
Safe staffing guidelines (0)
Social care guidelines (21)
Technology appraisal guidance (422)
Apply filters
Showing 651 to 700 of 700
Sort by
Date
Title
Apply sorting
Last updated date between 1/4/2018 and 28/3/2024
Remove Last updated date between 1/4/2018 and 28/3/2024 filter
Type: Guidance
Remove Type: Guidance filter
Type: Quality standard
Remove Type: Quality standard filter
Guidance programme: Technology appraisal guidance
Remove Guidance programme: Technology appraisal guidance filter
Guidance programme: Clinical guidelines
Remove Guidance programme: Clinical guidelines filter
Guidance programme: Medical technologies guidance
Remove Guidance programme: Medical technologies guidance filter
Guidance programme: Diagnostics guidance
Remove Guidance programme: Diagnostics guidance filter
Guidance programme: Highly specialised technologies guidance
Remove Guidance programme: Highly specialised technologies guidance filter
Guidance programme: Social care guidelines
Remove Guidance programme: Social care guidelines filter
Guidance programme: Antimicrobial prescribing guidelines
Remove Guidance programme: Antimicrobial prescribing guidelines filter
Guidance programme: Public health guidelines
Remove Guidance programme: Public health guidelines filter
Guidance programme: Cancer service guidelines
Remove Guidance programme: Cancer service guidelines filter
Guidance programme: Medicines practice guidelines
Remove Guidance programme: Medicines practice guidelines filter
Guidance programme: Safe staffing guidelines
Remove Guidance programme: Safe staffing guidelines filter
Published guidance, NICE advice and quality standards
Title
Reference number
Published
Last updated
Post-traumatic stress disorder
NG116
5 December 2018
5 December 2018
Chronic obstructive pulmonary disease (acute exacerbation): antimicrobial prescribing
NG114
5 December 2018
5 December 2018
Tofacitinib for moderately to severely active ulcerative colitis
TA547
28 November 2018
28 November 2018
Urinary tract infection (catheter-associated): antimicrobial prescribing
NG113
23 November 2018
23 November 2018
Padeliporfin for untreated localised prostate cancer
TA546
21 November 2018
21 November 2018
Gemtuzumab ozogamicin for untreated acute myeloid leukaemia
TA545
14 November 2018
14 November 2018
Urinary tract infection (lower): antimicrobial prescribing
NG109
31 October 2018
31 October 2018
Prostatitis (acute): antimicrobial prescribing
NG110
31 October 2018
31 October 2018
Pyelonephritis (acute): antimicrobial prescribing
NG111
31 October 2018
31 October 2018
Urinary tract infection (recurrent): antimicrobial prescribing
NG112
31 October 2018
31 October 2018
Eltrombopag for treating chronic immune thrombocytopenia
TA293
24 July 2013
26 October 2018
Romiplostim for the treatment of chronic immune thrombocytopenia
TA221
27 April 2011
26 October 2018
Myeloma: diagnosis and management
NG35
10 February 2016
25 October 2018
Dabrafenib with trametinib for adjuvant treatment of resected BRAF V600 mutation-positive melanoma
TA544
17 October 2018
17 October 2018
Lyme disease
NG95
11 April 2018
17 October 2018
Burosumab for treating X-linked hypophosphataemia in children and young people
HST8
10 October 2018
10 October 2018
Cabozantinib for untreated advanced renal cell carcinoma
TA542
3 October 2018
3 October 2018
Tofacitinib for treating active psoriatic arthritis after inadequate response to DMARDs
TA543
3 October 2018
3 October 2018
Renal replacement therapy and conservative management
NG107
3 October 2018
3 October 2018
Decision-making and mental capacity
NG108
3 October 2018
3 October 2018
E‑vita open plus for treating complex aneurysms and dissections of the thoracic aorta
MTG16
18 December 2013
1 October 2018
Inotuzumab ozogamicin for treating relapsed or refractory B-cell acute lymphoblastic leukaemia
TA541
19 September 2018
19 September 2018
Chronic heart failure in adults: diagnosis and management
NG106
12 September 2018
12 September 2018
Preventing suicide in community and custodial settings
NG105
10 September 2018
10 September 2018
Lutetium (177Lu) oxodotreotide for treating unresectable or metastatic neuroendocrine tumours
TA539
29 August 2018
29 August 2018
Dinutuximab beta for treating neuroblastoma
TA538
22 August 2018
22 August 2018
Flu vaccination: increasing uptake
NG103
22 August 2018
22 August 2018
Lenvatinib and sorafenib for treating differentiated thyroid cancer after radioactive iodine
TA535
8 August 2018
8 August 2018
Alectinib for untreated ALK-positive advanced non-small-cell lung cancer
TA536
8 August 2018
8 August 2018
Ixekizumab for treating active psoriatic arthritis after inadequate response to DMARDs
TA537
8 August 2018
8 August 2018
Community pharmacies: promoting health and wellbeing
NG102
2 August 2018
2 August 2018
Dupilumab for treating moderate to severe atopic dermatitis
TA534
1 August 2018
1 August 2018
Ocrelizumab for treating relapsing–remitting multiple sclerosis
TA533
25 July 2018
25 July 2018
Pembrolizumab for untreated PD-L1-positive metastatic non-small-cell lung cancer
TA531
18 July 2018
18 July 2018
Crizotinib for treating ROS1-positive advanced non-small-cell lung cancer
TA529
4 July 2018
4 July 2018
Nivolumab for treating locally advanced unresectable or metastatic urothelial cancer after platinum-containing chemotherapy
TA530
4 July 2018
4 July 2018
Biomarker tests to help diagnose preterm labour in women with intact membranes
DG33
4 July 2018
4 July 2018
Beta interferons and glatiramer acetate for treating multiple sclerosis
TA527
27 June 2018
27 June 2018
Donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer's disease
TA217
23 March 2011
20 June 2018
Dementia: assessment, management and support for people living with dementia and their carers
NG97
20 June 2018
20 June 2018
Guselkumab for treating moderate to severe plaque psoriasis
TA521
13 June 2018
13 June 2018
Midostaurin for untreated acute myeloid leukaemia
TA523
13 June 2018
13 June 2018
Brentuximab vedotin for treating CD30-positive Hodgkin lymphoma
TA524
13 June 2018
13 June 2018
Atezolizumab for treating locally advanced or metastatic urothelial carcinoma after platinum-containing chemotherapy
TA525
13 June 2018
13 June 2018
Arsenic trioxide for treating acute promyelocytic leukaemia
TA526
13 June 2018
13 June 2018
Cancer of the upper aerodigestive tract: assessment and management in people aged 16 and over
NG36
10 February 2016
6 June 2018
Atezolizumab for treating locally advanced or metastatic non-small-cell lung cancer after chemotherapy
TA520
16 May 2018
16 May 2018
Adjunctive colposcopy technologies for assessing suspected cervical abnormalities: the DYSIS colposcope with DYSISmap and the ZedScan I
DG32
25 April 2018
25 April 2018
Tocilizumab for treating giant cell arteritis
TA518
18 April 2018
18 April 2018
Care and support of people growing older with learning disabilities
NG96
11 April 2018
11 April 2018
Previous page
1
…
12
13
Current page
14
Page
14
of
14
Results per page
10
25
50
All
Back to top